Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease

Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease

Files

Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease.pdf(1.75 MB)

Date

2016

Authors

Wallentin, Lars

Armstrong, Paul W.

Cannon, Christopher P.

Davies, Richard Y.

Granger, Christopher B.

Harrington, Robert A.

Corbalán Herreros, Ramón

URI

https://doi.org/10.1161/JAHA.116.003407
https://repositorio.uc.cl/handle/11534/58054

Collections

Artículos de revistas